Price (delayed)
$6.5
Market cap
$3.25M
P/E Ratio
0.02
Dividend/share
N/A
EPS
$412.39
Enterprise value
$7.68M
22nd Century is a plant biotechnology company focused on technology which allows it to decrease the level of nicotine in tobacco plants and modify the levels of cannabinoids in hemp/cannabis
There are no recent dividends present for XXII.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.